Interestingly, CD70 is frequently expressed on T- and B-cell lymphomas and a significant fraction of solid tumors, such as thymic carcinoma, glioblastoma, renal cell carcinoma, osteosarcoma, and nasopharyngeal carcinoma [4–8]. Here, CD70 is linked to B-cell non-Hodgkin lymphoma.